280 related articles for article (PubMed ID: 26559321)
1. Persistence and evolution of allergen-specific IgE repertoires during subcutaneous specific immunotherapy.
Levin M; King JJ; Glanville J; Jackson KJ; Looney TJ; Hoh RA; Mari A; Andersson M; Greiff L; Fire AZ; Boyd SD; Ohlin M
J Allergy Clin Immunol; 2016 May; 137(5):1535-44. PubMed ID: 26559321
[TBL] [Abstract][Full Text] [Related]
2. Clonal evolution and stereotyped sequences of human IgE lineages in aeroallergen-specific immunotherapy.
Hoh RA; Thörnqvist L; Yang F; Godzwon M; King JJ; Lee JY; Greiff L; Boyd SD; Ohlin M
J Allergy Clin Immunol; 2023 Jul; 152(1):214-229. PubMed ID: 36828082
[TBL] [Abstract][Full Text] [Related]
3. Single B-cell deconvolution of peanut-specific antibody responses in allergic patients.
Hoh RA; Joshi SA; Liu Y; Wang C; Roskin KM; Lee JY; Pham T; Looney TJ; Jackson KJL; Dixit VP; King J; Lyu SC; Jenks J; Hamilton RG; Nadeau KC; Boyd SD
J Allergy Clin Immunol; 2016 Jan; 137(1):157-167. PubMed ID: 26152318
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.
Rossi RE; Monasterolo G
Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445
[TBL] [Abstract][Full Text] [Related]
5. Birch pollen immunotherapy results in long-term loss of Bet v 1-specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodies.
Möbs C; Ipsen H; Mayer L; Slotosch C; Petersen A; Würtzen PA; Hertl M; Pfützner W
J Allergy Clin Immunol; 2012 Nov; 130(5):1108-1116.e6. PubMed ID: 23021882
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment IgE sensitization patterns determine the molecular profile of the IgG4 response during updosing of subcutaneous immunotherapy with timothy grass pollen extract.
Schmid JM; Würtzen PA; Dahl R; Hoffmann HJ
J Allergy Clin Immunol; 2016 Feb; 137(2):562-70. PubMed ID: 26141262
[TBL] [Abstract][Full Text] [Related]
7. Decrease of allergen-specific T-cell response induced by local nasal immunotherapy.
Giannarini L; Maggi E
Clin Exp Allergy; 1998 Apr; 28(4):404-12. PubMed ID: 9641566
[TBL] [Abstract][Full Text] [Related]
8. Human B-cell isotype switching origins of IgE.
Looney TJ; Lee JY; Roskin KM; Hoh RA; King J; Glanville J; Liu Y; Pham TD; Dekker CL; Davis MM; Boyd SD
J Allergy Clin Immunol; 2016 Feb; 137(2):579-586.e7. PubMed ID: 26309181
[TBL] [Abstract][Full Text] [Related]
9. Allergen-specific immunotherapy: an update on immunological mechanisms of action.
Ciprandi G; Marseglia GL; Tosca MA
Monaldi Arch Chest Dis; 2006 Mar; 65(1):34-7. PubMed ID: 16700191
[TBL] [Abstract][Full Text] [Related]
10. High-dose bee venom exposure induces similar tolerogenic B-cell responses in allergic patients and healthy beekeepers.
Boonpiyathad T; Meyer N; Moniuszko M; Sokolowska M; Eljaszewicz A; Wirz OF; Tomasiak-Lozowska MM; Bodzenta-Lukaszyk A; Ruxrungtham K; van de Veen W
Allergy; 2017 Mar; 72(3):407-415. PubMed ID: 27341567
[TBL] [Abstract][Full Text] [Related]
11. Kinetics, cross-reactivity, and specificity of Bet v 1-specific IgG4 antibodies induced by immunotherapy with birch pollen.
Subbarayal B; Schiller D; Möbs C; de Jong NW; Ebner C; Reider N; Bartel D; Lidholm J; Pfützner W; Gerth van Wijk R; Vieths S; Bohle B
Allergy; 2013 Nov; 68(11):1377-86. PubMed ID: 24053565
[TBL] [Abstract][Full Text] [Related]
12. The role of IgG antibodies in allergy and immunotherapy.
Aalberse R
Allergy; 2011 Jul; 66 Suppl 95():28-30. PubMed ID: 21668848
[TBL] [Abstract][Full Text] [Related]
13. High-affinity IgG to a major A. fumigatus allergen, Asp f 2, retards allergic response.
Svirshchevskaya EV; Viskova N; Shevchenko M; Alekseeva L; Marchenko A; Benevolensky S; Kurup VP
Med Sci Monit; 2004 Oct; 10(10):BR371-80. PubMed ID: 15448590
[TBL] [Abstract][Full Text] [Related]
14. Allergen-specific IgG
Hoof I; Schulten V; Layhadi JA; Stranzl T; Christensen LH; Herrera de la Mata S; Seumois G; Vijayanand P; Lundegaard C; Niss K; Lund A; Ahrenfeldt J; Holm J; Steveling E; Sharif H; Durham SR; Peters B; Shamji MH; Andersen PS
J Allergy Clin Immunol; 2020 Jul; 146(1):180-191. PubMed ID: 31883847
[TBL] [Abstract][Full Text] [Related]
15. The human IgE repertoire.
Gadermaier E; Levin M; Flicker S; Ohlin M
Int Arch Allergy Immunol; 2014; 163(2):77-91. PubMed ID: 24296690
[TBL] [Abstract][Full Text] [Related]
16. Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial.
Senti G; Johansen P; Haug S; Bull C; Gottschaller C; Müller P; Pfister T; Maurer P; Bachmann MF; Graf N; Kündig TM
Clin Exp Allergy; 2009 Apr; 39(4):562-70. PubMed ID: 19226280
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of subcutaneous allergen immunotherapy.
Soyer OU; Akdis M; Akdis CA
Immunol Allergy Clin North Am; 2011 May; 31(2):175-90, vii-viii. PubMed ID: 21530813
[TBL] [Abstract][Full Text] [Related]
18. The complexity of allergic patients' IgE repertoire correlates with serum concentration of allergen-specific IgE.
Willumsen N; Holm J; Christensen LH; Würtzen PA; Lund K
Clin Exp Allergy; 2012 Aug; 42(8):1227-36. PubMed ID: 22805470
[TBL] [Abstract][Full Text] [Related]
19. Treating cat allergy with monoclonal IgG antibodies that bind allergen and prevent IgE engagement.
Orengo JM; Radin AR; Kamat V; Badithe A; Ben LH; Bennett BL; Zhong S; Birchard D; Limnander A; Rafique A; Bautista J; Kostic A; Newell D; Duan X; Franklin MC; Olson W; Huang T; Gandhi NA; Lipsich L; Stahl N; Papadopoulos NJ; Murphy AJ; Yancopoulos GD
Nat Commun; 2018 Apr; 9(1):1421. PubMed ID: 29650949
[TBL] [Abstract][Full Text] [Related]
20. Allergen-related approaches to immunotherapy.
Rolland JM; Gardner LM; O'Hehir RE
Pharmacol Ther; 2009 Mar; 121(3):273-84. PubMed ID: 19111571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
